首页 > 市场调查报告书 > 製药

癌症生物製剂

市场调查报告书

商品编码

1298705

癌症免疫疗法市场：2023-2028年全球行业趋势、份额、规模、增长、机会和预测

Cancer Immunotherapy Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

出版日期: 2023年06月14日 | 出版商:

IMARC | 英文 145 Pages | 商品交期: 2-3个工作天内

价格

简介目录图表

2022年，全球癌症免疫治疗市场规模达到1067亿美元。展望未来，IMARC集团预计，到2028年，市场规模将达到1820亿美元，在2023-2028年期间，增长率（CAGR）为8.8%。癌症病例数量的增长、政府的有利倡议以及医疗保险的广泛普及是推动市场发展的一些关键因素。

癌症是指一种疾病，身体中的一些细胞不受控制地生长，并扩散到身体的几个部分。它是由饮酒或吸烟、不健康的饮食、空气污染和不运动引起的。它可以导致严重的健康问题，如焦虑、抑郁、对死亡的恐惧、疼痛、压力和个人的自杀念头。它可以通过免疫疗法进行治疗，免疫疗法包括结合并抑制癌细胞所表达的蛋白质功能的抗体。癌症免疫疗法有助于提高免疫系统，以检测和摧毁个人中的异常癌细胞。除此之外，与其他治疗方案相比，它引起的副作用更少，并减少了发生癌细胞的几率。因此，癌症免疫疗法被广泛用于治疗全球个人的肺癌、乳腺癌、结肠直肠癌、黑色素瘤、前列腺、头颈部、甲状腺、肾脏、肝脏、宫颈、膀胱、卵巢和皮肤癌。

癌症免疫疗法市场趋势和驱动因素：

目前，由于世界各地的人饮食不均衡和食用有毒物质，导致癌症病例不断增加，这是积极影响市场的主要因素之一。此外，全球群众对各种癌症治疗方案的认识不断提高，也促进了市场的增长。除此之外，癌症免疫疗法的使用越来越多，因为与抗肿瘤疗法相比，它们提供了更长的无进展生存期（PFS）和总生存期（OS），正在提供一个积极的市场前景。此外，医疗保险的广泛提供和容易获得，以及医疗支出的增加，正在为行业投资者提供有利可图的增长机会。此外，世界各地的群众对副作用较少的治疗方案的需求也在增加。这一点，再加上由于新型免疫疗法获得越来越多的批准而越来越多地采用癌症免疫疗法，正在促进市场的增长。与此相呼应，各国的管理机构和非营利组织正在鼓励采用癌症免疫疗法，在全球范围内传播预防癌症的意识，这推动了市场的增长。此外，癌症治疗疗法的各种技术进步，有效地治疗疾病，正在加强市场的增长。

本报告中回答的关键问题：

迄今为止，全球癌症免疫治疗市场的表现如何，在未来几年内将如何表现？
全球癌症免疫疗法市场的驱动因素、限制因素和机会是什么？
每个驱动因素、限制因素和机会对全球癌症免疫治疗市场的影响是什么？
主要的区域市场是什么？
哪些国家代表了最具吸引力的癌症免疫治疗市场？
基于治疗类型的市场细分是什么？
癌症免疫治疗市场中最有吸引力的治疗类型是什么？
基于应用的市场细分是什么？
癌症免疫治疗市场中最有吸引力的应用是什么？
基于终端用户的市场细分是什么？
哪个是癌症免疫治疗市场中最有吸引力的终端用户？
全球癌症免疫治疗市场的竞争结构是什么？
谁是全球癌症免疫疗法市场的主要参与者/公司？

北美洲
- 美国
  - 市场趋势
  - 市场预测
- 加拿大
  - 市场趋势
  - 市场预测
亚太地区
- 中国
  - 市场趋势
  - 市场预测
- 日本
  - 市场趋势
  - 市场预测
- 印度
  - 市场趋势
  - 市场预测
- 韩国
  - 市场趋势
  - 市场预测
- 澳大利亚
  - 市场趋势
  - 市场预测
- 印尼
  - 市场趋势
  - 市场预测
- 其他国家
  - 市场趋势
  - 市场预测
欧洲
- 德国
  - 市场趋势
  - 市场预测
- 法国
  - 市场趋势
  - 市场预测
- 英国
  - 市场趋势
  - 市场预测
- 意大利
  - 市场趋势
  - 市场预测
- 西班牙
  - 市场趋势
  - 市场预测
- 俄罗斯
  - 市场趋势
  - 市场预测
- 其他国家
  - 市场趋势
  - 市场预测
拉丁美洲
- 巴西
  - 市场趋势
  - 市场预测
- 墨西哥
  - 市场趋势
  - 市场预测
- 其他国家
  - 市场趋势
  - 市场预测
中东和非洲
- 市场趋势
- 按国家分類的市场
- 市场预测

第十章：SWOT分析

概述
优势
劣势
机会
威胁

第十一章：价值链分析

第十二章：波特斯五力分析

概述
买方的讨价还价能力
供应商的讨价还价能力
竞争程度
新进入者的威胁
替代品的威胁

第十三章：价格分析

第十四章：竞争格局

市场结构
主要参与者
主要参与者的概况
- Amgen Inc.
- AstraZeneca plc
- Bayer AG
- Bristol-Myers Squibb Company
- Eli Lilly and Company
- F. Hoffmann-La Roche AG
- GlaxoSmithKline Plc
- Johnson & Johnson
- Merck KGAA
- Novartis AG
- Pfizer Inc.
- Sanofi
- Seagen Inc.

简介目录图表

Product Code: SR112023A5095

The global cancer immunotherapy market size reached US$ 106.7 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 182.0 Billion by 2028, exhibiting a growth rate (CAGR) of 8.8% during 2023-2028. The growing number of cancer cases, favorable government initiatives, and wide availability of medical insurance represent some of the key factors driving the market.

Cancer refers to a disease wherein some of the cells in the body grow uncontrollably and spread across several body parts. It is caused by alcohol or tobacco consumption, an unhealthy diet, air pollution, and physical inactivity. It can lead to severe health problems, such as anxiety, depression, fear of death, pain, stress, and suicidal thoughts among individuals. It can be treated through immunotherapy, which comprises antibodies that bind, and inhibit the function of proteins expressed by cancer cells. Cancer immunotherapy assists in boosting the immune system to detect and destroy abnormal cancer cells among individuals. Besides this, it causes fewer side effects as compared to other treatment options and reduces the chances of occurring cancerous cells. As a result, cancer immunotherapy is widely utilized to treat lung, breast, colorectal, melanoma, prostate, head and neck, thyroid, kidney, liver, cervical, bladder, ovarian, and skin cancers among individuals across the globe.

Cancer Immunotherapy Market Trends and Drivers:

At present, the increasing number of cancer cases due to the poor balanced diet and consumption of toxic substances among individuals around the world represents one of the major factors influencing the market positively. In addition, the rising awareness about various cancer treatment options among the masses across the globe is contributing to the market growth. Apart from this, the growing utilization of cancer immunotherapies, as they provide prolonged progression-free survival (PFS) and overall survival (OS) compared to anti-tumor therapies, is offering a positive market outlook. Moreover, the wide availability and easy access to medical insurance, along with the increasing healthcare expenditure, is offering lucrative growth opportunities to industry investors. In addition, there is a rise in the demand for treatment solutions with fewer side effects among the masses around the world. This, coupled with the growing adoption of cancer immunotherapies due to the increasing approval for novel immunotherapies, is bolstering the growth of the market. In line with this, governing agencies and non-profit organizations of various countries are encouraging the adoption of cancer immunotherapy by spreading awareness about cancer prevention worldwide is impelling the growth of the market. Furthermore, various technological advancements in cancer treatment therapies to efficiently treat the disease are strengthening the growth of the market.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global cancer immunotherapy market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on therapy type, application and end user.

Therapy Type Insights:

Monoclonal Antibodies

Cancer Vaccines

Checkpoint Inhibitors

Immunomodulators

Others

The report has provided a detailed breakup and analysis of the cancer immunotherapy market based on the therapy type. This includes monoclonal antibodies, cancer vaccines, checkpoint inhibitors, immunomodulators, and others. According to the report, monoclonal antibodies represented the largest segment.

Application Insights:

Lung Cancer

Breast Cancer

Colorectal Cancer

Melanoma

Prostate Cancer

Head and Neck Cancer

Others

A detailed breakup and analysis of the cancer immunotherapy market based on the application has also been provided in the report. This includes lung cancer, breast cancer, colorectal cancer, melanoma, prostate cancer, head and neck cancer, and others. According to the report, lung cancer accounted for the largest market share.

End User Insights:

Hospitals

Cancer Research Centers

Clinics

Others

A detailed breakup and analysis of the cancer immunotherapy market based on the end user has also been provided in the report. This includes hospitals, cancer research centers, clinics, and others. According to the report, hospitals accounted for the largest market share.

Regional Insights:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America (the United States and Canada) was the largest market for cancer immunotherapy. Some of the factors driving the North America cancer immunotherapy market included the growing number of patients suffering from cancer, rising development of bioinformatic tools, favorable government initiatives, etc.

Competitive Landscape:

The report has also provided a comprehensive analysis of the competitive landscape in the global cancer immunotherapy market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include Amgen Inc., AstraZeneca plc, Bayer AG, Bristol-Myers Squibb Company, Eli Lilly and Company, F. Hoffmann-La Roche AG, GlaxoSmithKline Plc, Johnson & Johnson, Merck KGAA, Novartis AG, Pfizer Inc., Sanofi, Seagen Inc., etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

Key Questions Answered in This Report:

How has the global cancer immunotherapy market performed so far, and how will it perform in the coming years?
What are the drivers, restraints, and opportunities in the global cancer immunotherapy market?
What is the impact of each driver, restraint, and opportunity on the global cancer immunotherapy market?
What are the key regional markets?
Which countries represent the most attractive cancer immunotherapy market?
What is the breakup of the market based on the therapy type?
Which is the most attractive therapy type in the cancer immunotherapy market?
What is the breakup of the market based on the application?
Which is the most attractive application in the cancer immunotherapy market?
What is the breakup of the market based on the end user?
Which is the most attractive end user in the cancer immunotherapy market?
What is the competitive structure of the global cancer immunotherapy market?
Who are the key players/companies in the global cancer immunotherapy market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

4.1 Overview
4.2 Key Industry Trends

5 Global Cancer Immunotherapy Market

5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Therapy Type

6.1 Monoclonal Antibodies
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
6.2 Cancer Vaccines
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
6.3 Checkpoint Inhibitors
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
6.4 Immunomodulators
- 6.4.1 Market Trends
- 6.4.2 Market Forecast
6.5 Others
- 6.5.1 Market Trends
- 6.5.2 Market Forecast

7 Market Breakup by Application

7.1 Lung Cancer
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
7.2 Breast Cancer
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
7.3 Colorectal Cancer
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
7.4 Melanoma
- 7.4.1 Market Trends
- 7.4.2 Market Forecast
7.5 Prostate Cancer
- 7.5.1 Market Trends
- 7.5.2 Market Forecast
7.6 Head and Neck Cancer
- 7.6.1 Market Trends
- 7.6.2 Market Forecast
7.7 Others
- 7.7.1 Market Trends
- 7.7.2 Market Forecast

8 Market Breakup by End User

8.1 Hospitals
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
8.2 Cancer Research Centers
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
8.3 Clinics
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
8.4 Others
- 8.4.1 Market Trends
- 8.4.2 Market Forecast

9 Market Breakup by Region

9.1 North America
- 9.1.1 United States
  - 9.1.1.1 Market Trends
  - 9.1.1.2 Market Forecast
- 9.1.2 Canada
  - 9.1.2.1 Market Trends
  - 9.1.2.2 Market Forecast
9.2 Asia-Pacific
- 9.2.1 China
  - 9.2.1.1 Market Trends
  - 9.2.1.2 Market Forecast
- 9.2.2 Japan
  - 9.2.2.1 Market Trends
  - 9.2.2.2 Market Forecast
- 9.2.3 India
  - 9.2.3.1 Market Trends
  - 9.2.3.2 Market Forecast
- 9.2.4 South Korea
  - 9.2.4.1 Market Trends
  - 9.2.4.2 Market Forecast
- 9.2.5 Australia
  - 9.2.5.1 Market Trends
  - 9.2.5.2 Market Forecast
- 9.2.6 Indonesia
  - 9.2.6.1 Market Trends
  - 9.2.6.2 Market Forecast
- 9.2.7 Others
  - 9.2.7.1 Market Trends
  - 9.2.7.2 Market Forecast
9.3 Europe
- 9.3.1 Germany
  - 9.3.1.1 Market Trends
  - 9.3.1.2 Market Forecast
- 9.3.2 France
  - 9.3.2.1 Market Trends
  - 9.3.2.2 Market Forecast
- 9.3.3 United Kingdom
  - 9.3.3.1 Market Trends
  - 9.3.3.2 Market Forecast
- 9.3.4 Italy
  - 9.3.4.1 Market Trends
  - 9.3.4.2 Market Forecast
- 9.3.5 Spain
  - 9.3.5.1 Market Trends
  - 9.3.5.2 Market Forecast
- 9.3.6 Russia
  - 9.3.6.1 Market Trends
  - 9.3.6.2 Market Forecast
- 9.3.7 Others
  - 9.3.7.1 Market Trends
  - 9.3.7.2 Market Forecast
9.4 Latin America
- 9.4.1 Brazil
  - 9.4.1.1 Market Trends
  - 9.4.1.2 Market Forecast
- 9.4.2 Mexico
  - 9.4.2.1 Market Trends
  - 9.4.2.2 Market Forecast
- 9.4.3 Others
  - 9.4.3.1 Market Trends
  - 9.4.3.2 Market Forecast
9.5 Middle East and Africa
- 9.5.1 Market Trends
- 9.5.2 Market Breakup by Country
- 9.5.3 Market Forecast

10 SWOT Analysis

10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
- 14.3.1 Amgen Inc.
  - 14.3.1.1 Company Overview
  - 14.3.1.2 Product Portfolio
  - 14.3.1.3 Financials
  - 14.3.1.4 SWOT Analysis
- 14.3.2 AstraZeneca plc
  - 14.3.2.1 Company Overview
  - 14.3.2.2 Product Portfolio
  - 14.3.2.3 Financials
  - 14.3.2.4 SWOT Analysis
- 14.3.3 Bayer AG
  - 14.3.3.1 Company Overview
  - 14.3.3.2 Product Portfolio
  - 14.3.3.3 Financials
  - 14.3.3.4 SWOT Analysis
- 14.3.4 Bristol-Myers Squibb Company
  - 14.3.4.1 Company Overview
  - 14.3.4.2 Product Portfolio
  - 14.3.4.3 Financials
  - 14.3.4.4 SWOT Analysis
- 14.3.5 Eli Lilly and Company
  - 14.3.5.1 Company Overview
  - 14.3.5.2 Product Portfolio
  - 14.3.5.3 Financials
  - 14.3.5.4 SWOT Analysis
- 14.3.6 F. Hoffmann-La Roche AG
  - 14.3.6.1 Company Overview
  - 14.3.6.2 Product Portfolio
  - 14.3.6.3 SWOT Analysis
- 14.3.7 GlaxoSmithKline Plc
  - 14.3.7.1 Company Overview
  - 14.3.7.2 Product Portfolio
  - 14.3.7.3 Financials
  - 14.3.7.4 SWOT Analysis
- 14.3.8 Johnson & Johnson
  - 14.3.8.1 Company Overview
  - 14.3.8.2 Product Portfolio
  - 14.3.8.3 Financials
  - 14.3.8.4 SWOT Analysis
- 14.3.9 Merck KGAA
  - 14.3.9.1 Company Overview
  - 14.3.9.2 Product Portfolio
  - 14.3.9.3 Financials
  - 14.3.9.4 SWOT Analysis
- 14.3.10 Novartis AG
  - 14.3.10.1 Company Overview
  - 14.3.10.2 Product Portfolio
  - 14.3.10.3 Financials
  - 14.3.10.4 SWOT Analysis
- 14.3.11 Pfizer Inc.
  - 14.3.11.1 Company Overview
  - 14.3.11.2 Product Portfolio
  - 14.3.11.3 Financials
  - 14.3.11.4 SWOT Analysis
- 14.3.12 Sanofi
  - 14.3.12.1 Company Overview
  - 14.3.12.2 Product Portfolio
  - 14.3.12.3 Financials
  - 14.3.12.4 SWOT Analysis
- 14.3.13 Seagen Inc.
  - 14.3.13.1 Company Overview
  - 14.3.13.2 Product Portfolio
  - 14.3.13.3 Financials
  - 14.3.13.4 SWOT Analysis

简介目录图表

List of Figures

Figure 1: Global: Cancer Immunotherapy Market: Major Drivers and Challenges
Figure 2: Global: Cancer Immunotherapy Market: Sales Value (in Billion US$), 2017-2022
Figure 3: Global: Cancer Immunotherapy Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 4: Global: Cancer Immunotherapy Market: Breakup by Therapy Type (in %), 2022
Figure 5: Global: Cancer Immunotherapy Market: Breakup by Application (in %), 2022
Figure 6: Global: Cancer Immunotherapy Market: Breakup by End User (in %), 2022
Figure 7: Global: Cancer Immunotherapy Market: Breakup by Region (in %), 2022
Figure 8: Global: Cancer Immunotherapy (Monoclonal Antibodies) Market: Sales Value (in Million US$), 2017 & 2022
Figure 9: Global: Cancer Immunotherapy (Monoclonal Antibodies) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 10: Global: Cancer Immunotherapy (Cancer Vaccines) Market: Sales Value (in Million US$), 2017 & 2022
Figure 11: Global: Cancer Immunotherapy (Cancer Vaccines) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 12: Global: Cancer Immunotherapy (Checkpoint Inhibitors) Market: Sales Value (in Million US$), 2017 & 2022
Figure 13: Global: Cancer Immunotherapy (Checkpoint Inhibitors) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 14: Global: Cancer Immunotherapy (Immunomodulators) Market: Sales Value (in Million US$), 2017 & 2022
Figure 15: Global: Cancer Immunotherapy (Immunomodulators) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 16: Global: Cancer Immunotherapy (Other Therapy Types) Market: Sales Value (in Million US$), 2017 & 2022
Figure 17: Global: Cancer Immunotherapy (Other Therapy Types) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 18: Global: Cancer Immunotherapy (Lung Cancer) Market: Sales Value (in Million US$), 2017 & 2022
Figure 19: Global: Cancer Immunotherapy (Lung Cancer) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 20: Global: Cancer Immunotherapy (Breast Cancer) Market: Sales Value (in Million US$), 2017 & 2022
Figure 21: Global: Cancer Immunotherapy (Breast Cancer) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 22: Global: Cancer Immunotherapy (Colorectal Cancer) Market: Sales Value (in Million US$), 2017 & 2022
Figure 23: Global: Cancer Immunotherapy (Colorectal Cancer) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 24: Global: Cancer Immunotherapy (Melanoma) Market: Sales Value (in Million US$), 2017 & 2022
Figure 25: Global: Cancer Immunotherapy (Melanoma) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 26: Global: Cancer Immunotherapy (Prostate Cancer) Market: Sales Value (in Million US$), 2017 & 2022
Figure 27: Global: Cancer Immunotherapy (Prostate Cancer) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 28: Global: Cancer Immunotherapy (Head and Neck Cancer) Market: Sales Value (in Million US$), 2017 & 2022
Figure 29: Global: Cancer Immunotherapy (Head and Neck Cancer) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 30: Global: Cancer Immunotherapy (Other Applications) Market: Sales Value (in Million US$), 2017 & 2022
Figure 31: Global: Cancer Immunotherapy (Other Applications) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 32: Global: Cancer Immunotherapy (Hospitals) Market: Sales Value (in Million US$), 2017 & 2022
Figure 33: Global: Cancer Immunotherapy (Hospitals) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 34: Global: Cancer Immunotherapy (Cancer Research Centers) Market: Sales Value (in Million US$), 2017 & 2022
Figure 35: Global: Cancer Immunotherapy (Cancer Research Centers) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 36: Global: Cancer Immunotherapy (Clinics) Market: Sales Value (in Million US$), 2017 & 2022
Figure 37: Global: Cancer Immunotherapy (Clinics) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 38: Global: Cancer Immunotherapy (Other End Users) Market: Sales Value (in Million US$), 2017 & 2022
Figure 39: Global: Cancer Immunotherapy (Other End Users) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 40: North America: Cancer Immunotherapy Market: Sales Value (in Million US$), 2017 & 2022
Figure 41: North America: Cancer Immunotherapy Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 42: United States: Cancer Immunotherapy Market: Sales Value (in Million US$), 2017 & 2022
Figure 43: United States: Cancer Immunotherapy Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 44: Canada: Cancer Immunotherapy Market: Sales Value (in Million US$), 2017 & 2022
Figure 45: Canada: Cancer Immunotherapy Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 46: Asia-Pacific: Cancer Immunotherapy Market: Sales Value (in Million US$), 2017 & 2022
Figure 47: Asia-Pacific: Cancer Immunotherapy Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 48: China: Cancer Immunotherapy Market: Sales Value (in Million US$), 2017 & 2022
Figure 49: China: Cancer Immunotherapy Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 50: Japan: Cancer Immunotherapy Market: Sales Value (in Million US$), 2017 & 2022
Figure 51: Japan: Cancer Immunotherapy Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 52: India: Cancer Immunotherapy Market: Sales Value (in Million US$), 2017 & 2022
Figure 53: India: Cancer Immunotherapy Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 54: South Korea: Cancer Immunotherapy Market: Sales Value (in Million US$), 2017 & 2022
Figure 55: South Korea: Cancer Immunotherapy Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 56: Australia: Cancer Immunotherapy Market: Sales Value (in Million US$), 2017 & 2022
Figure 57: Australia: Cancer Immunotherapy Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 58: Indonesia: Cancer Immunotherapy Market: Sales Value (in Million US$), 2017 & 2022
Figure 59: Indonesia: Cancer Immunotherapy Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 60: Others: Cancer Immunotherapy Market: Sales Value (in Million US$), 2017 & 2022
Figure 61: Others: Cancer Immunotherapy Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 62: Europe: Cancer Immunotherapy Market: Sales Value (in Million US$), 2017 & 2022
Figure 63: Europe: Cancer Immunotherapy Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 64: Germany: Cancer Immunotherapy Market: Sales Value (in Million US$), 2017 & 2022
Figure 65: Germany: Cancer Immunotherapy Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 66: France: Cancer Immunotherapy Market: Sales Value (in Million US$), 2017 & 2022
Figure 67: France: Cancer Immunotherapy Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 68: United Kingdom: Cancer Immunotherapy Market: Sales Value (in Million US$), 2017 & 2022
Figure 69: United Kingdom: Cancer Immunotherapy Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 70: Italy: Cancer Immunotherapy Market: Sales Value (in Million US$), 2017 & 2022
Figure 71: Italy: Cancer Immunotherapy Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 72: Spain: Cancer Immunotherapy Market: Sales Value (in Million US$), 2017 & 2022
Figure 73: Spain: Cancer Immunotherapy Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 74: Russia: Cancer Immunotherapy Market: Sales Value (in Million US$), 2017 & 2022
Figure 75: Russia: Cancer Immunotherapy Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 76: Others: Cancer Immunotherapy Market: Sales Value (in Million US$), 2017 & 2022
Figure 77: Others: Cancer Immunotherapy Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 78: Latin America: Cancer Immunotherapy Market: Sales Value (in Million US$), 2017 & 2022
Figure 79: Latin America: Cancer Immunotherapy Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 80: Brazil: Cancer Immunotherapy Market: Sales Value (in Million US$), 2017 & 2022
Figure 81: Brazil: Cancer Immunotherapy Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 82: Mexico: Cancer Immunotherapy Market: Sales Value (in Million US$), 2017 & 2022
Figure 83: Mexico: Cancer Immunotherapy Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 84: Others: Cancer Immunotherapy Market: Sales Value (in Million US$), 2017 & 2022
Figure 85: Others: Cancer Immunotherapy Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 86: Middle East and Africa: Cancer Immunotherapy Market: Sales Value (in Million US$), 2017 & 2022
Figure 87: Middle East and Africa: Cancer Immunotherapy Market: Breakup by Country (in %), 2022
Figure 88: Middle East and Africa: Cancer Immunotherapy Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 89: Global: Cancer Immunotherapy Industry: SWOT Analysis
Figure 90: Global: Cancer Immunotherapy Industry: Value Chain Analysis
Figure 91: Global: Cancer Immunotherapy Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Cancer Immunotherapy Market: Key Industry Highlights, 2022 and 2028
Table 2: Global: Cancer Immunotherapy Market Forecast: Breakup by Therapy Type (in Million US$), 2023-2028
Table 3: Global: Cancer Immunotherapy Market Forecast: Breakup by Application (in Million US$), 2023-2028
Table 4: Global: Cancer Immunotherapy Market Forecast: Breakup by End User (in Million US$), 2023-2028
Table 5: Global: Cancer Immunotherapy Market Forecast: Breakup by Region (in Million US$), 2023-2028
Table 6: Global: Cancer Immunotherapy Market: Competitive Structure
Table 7: Global: Cancer Immunotherapy Market: Key Players

02-2729-4219

+886-2-2729-4219